SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab
Autor: | Marques-Piubelli, Mario L. *, Parra, Edwin R. *, Feng, Lei, Soto, Luisa Solis, Gallardo, Mariana, Gouni, Sushanth, Samaniego, Felipe, Noorani, Mansoor, Hagemeister, Fredrick B., Westin, Jason R., Lee, Hun Ju, Rodriguez, Maria A., Neelapu, Sattva S., Gunther, Jillian R., Fowler, Nathan H., Flowers, Christopher R., Wistuba, Ignacio I., Nastoupil, Loretta J. *, Vega, Francisco *, Strati, Paolo *, * |
---|---|
Zdroj: | In Blood Advances 14 June 2022 6(11):3286-3293 |
Databáze: | ScienceDirect |
Externí odkaz: |